Antiphospholipid Syndromes with Anti-Human β₂-Glycoprotein I Antibodies despite Negative Reactivity in Conventional aPL and LA Assays

• References

• 1 McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation:β₂-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4142
• 2 Roubey RAS, Eisenberg RA, Harper MF, Winfield JB. “Anticardiolipin” autoantibodies recognize β-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding. J Immunol 1995; 154: 954-960
• 3 Keeling DM, Wilson AJG, Mackie IJ, Machin SJ, Isenberg DA. Some antiphospholipid antibodies bind to β₂-glycoprotein I in the absence of phospholipid. Br J Haematol 1992; 82: 571-574
• 4 Arvieux J, Damige E, Hachulla E, Roussel B, Bensa JC, Colomb MG. Species specificity of anti-β₂-glycoprotein I autoantibodies and its relevance to anticardiolipin antibody quantification. Thromb Haemost 1996; 75: 725-730
• 5 Viard JP, Amoura Z, Bach JF. Association of anti-β₂-gly coprotein I with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992; 93: 181-186
• 6 Balestrieri G, Tincani A, Spatola L, Allegri F, Prati E, Cattaneo R, Valesini G, Del Papa N, Meroni P. Anti-beta₂-glycoprotein I antibodies: a marker of antiphospholipid syndrome? Lupus. 1995; 4: 122-130
• 7 Roubey RAS, Maldonado MA, Byrd SN. Comparison of an enzyme-linked immunosorbent assay for antibodies to β₂-glycoprotein I and a conventional anticardiolipin immunoassay. Arthritis Rheum 1996; 39: 1606-1607
• 8 Cabiedes J, Cabral AR, Alarcon-Segovia D. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-β₂-glycoprotein I than with antiphospholipid antibodies. J Rheumatol 1995; 22: 1899-1906
• 9 Exner T, Triplett DA, Tabemer D, Machin S. Guidelines for testing and revised criteria for lupus anticoagulants. Thromb Haemost 1991; 65: 320-322
• 10 Thiagarajan P, Pengo V, Shapiro SS. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants. Blood 1986; 68: 869-874
• 11 Sanmarco M, Soler C. Heterogeneity of anti-β₂-glycoprotein I antibodies. Nouv Rev Fr Hematol 1995; 37: 57-60
• 12 Sammaritano LR, Lockshin MD, Gharavi AE. Antiphospholipid antibodies differ in aPL cofactor requirement. Lupus 1992; 1: 83-90